Results 321 to 330 of about 924,600 (401)

Variations in alcohol craving and negative mood during a clinical trial of ibudilast for alcohol use disorder

open access: yesAlcohol, Clinical and Experimental Research, EarlyView.
Neuroimmune compounds are being investigated as novel treatments for alcohol use disorder (AUD). This secondary analysis of a randomized clinical trial of ibudilast for AUD (N = 102) evaluated changes in self‐report symptom measures of craving, depression, and anxiety collected monthly over 12 weeks.
Lindsay R. Meredith   +3 more
wiley   +1 more source

Perspective on insomnia in disorders of consciousness

open access: yes
Sleep Research, EarlyView.
Glenn J. M. van der Lande, Jitka Annen
wiley   +1 more source

Potential TMS biomarkers for GABAB receptor engagement in alcohol use disorder: A systematic review of existing evidence

open access: yesAlcohol, Clinical and Experimental Research, EarlyView.
This systematic review emphasizes the critical role of GABAB receptors (GABABR) in alcohol use disorder (AUD). While GABABR agonists enhance cortical inhibition, as measured by transcranial magnetic stimulation (TMS)‐based markers, alcohol consumption alters GABABR ‐dependent neurophysiological measures, suggesting GABABR dysfunction plays a key role ...
Chiara Montemitro   +4 more
wiley   +1 more source

Childhood Maltreatment and Cognitive Functioning in Bipolar Disorder: A Systematic Review and Meta‐Analysis

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Aims Characterising the association between childhood maltreatment (CM) and cognitive functioning in bipolar disorder (BD) is crucial for improving the understanding of how early environmental risk factors impact the presentation of the disorder.
Natalia E. Fares‐Otero   +7 more
wiley   +1 more source

Psychopathic Traits Associate With Later Schizophrenia

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Despite well‐known diagnostic and neurobiological overlaps between psychopathic traits and schizophrenia, it has remained unclear whether psychopathic traits increase the risk for later schizophrenia. Former studies have proven only a weak correlation between psychopathy and DSM axis I diagnoses.
Olli Vaurio   +3 more
wiley   +1 more source

Pharmacological and Mechanistic Interventions for Cognitive Impairment Associated With Schizophrenia: A Review of Registered Clinical Trials

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Background Schizophrenia is characterized by positive, negative, and cognitive symptoms. Current pharmacological treatments often fail to address cognitive deficits. In this review of clinical trials, we aim to identify studies that explore neurobiological (non‐psychological) strategies to address Cognitive Impairment Associated with ...
Bahareh Peyrovian   +3 more
wiley   +1 more source

Predicting Response to Pro‐Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force

open access: yesActa Psychiatrica Scandinavica, EarlyView.
ABSTRACT Introduction Major depressive disorder (MDD) and bipolar disorder (BD) are often associated with persistent cognitive deficits that impair psychosocial functioning. While pro‐cognitive interventions show promise, trial findings are inconsistent, potentially due to baseline factors influencing treatment response.
Dimosthenis Tsapekos   +30 more
wiley   +1 more source

Home - About - Disclaimer - Privacy